Cashu | News | BIO

HomeWatchlistNewsSignalsPicks

DJI

+2.81%

SPX

+3.26%

IXIC

+4.35%

FTSE

+0.21%

N225

+1.43%

AXJO

+0.43%

HomeWatchlistNewsSignalsPicks

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest BioRad Laboratories News

HILLHURST BIO RECEIVES GRANT SUBAWARD FROM THE FARMER FAMILY FOUNDATION AND GRANT AWARD FROM THE MICHAEL J. FOX FOUNDATION TO ADVANCE CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE

J INTS BIO Presents Research Results for Next-Generation Innovative Anticancer Therapeutics 'JIN-A02' and 'JIN-001' at AACR 2025

Feature Image for interests on Clinical Trials & Medical Discoveries, Healthcare, Industrials, Medical Pharmaceuticals from prnewswire.com

BIO Asia-Taiwan Kicks Off on an Expanded Scale July 23

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Equipment from prnewswire.com

ARKEMA ANNOUNCES BIO PERFORMANCE RHEOLOGY ADDITIVES PRODUCTION IN EUROPE

about 1 month ago

Alger Russell Innovation Index Updates for First Quarter 2025

Feature Image for interests on Banking & Financial Services, Basic Materials, Healthcare, Mutual Funds from prnewswire.com

about 2 months ago

Genprex to Participate at BIO Europe Spring 2025

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Consumer Cyclical, Health Care & Hospitals from prnewswire.com

businesswire.com

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Feature Image for interests on Healthcare, Stock from businesswire.com

businesswire.com

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Feature Image for interests on Healthcare, Stock from businesswire.com

businesswire.com

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Feature Image for interests on Healthcare, Stock from businesswire.com

Stocks

Health Care

bio

BioRad Laboratories

BIO

+17.74 (+7.43%)

256.42

USD

At close at May 12, 20:39 UTC

Latest Cashu News

BioRad Laboratories' Partner Hillhurst Biopharmaceuticals Secures Funding for Parkinson's Clinical Study

BioRad Laboratories Supports Hillhurst's $6.3M Parkinson's Research Initiative

BioRad Laboratories Highlights J INTS BIO's Breakthrough NSCLC Therapy at AACR 2025